Aeglea: Q2 Earnings Snapshot
AUSTIN, Texas (AP) _ Aeglea Biotherapeutics Inc. (AGLE) on Thursday reported a loss of $22.3 million in its second quarter.
On a per-share basis, the Austin, Texas-based company said it had a loss of 27 cents.
The biopharmaceutical company posted revenue of $625,000 in the period.
The company’s shares closed at 39 cents. A year ago, they were trading at $6.27.